Prosecution Insights
Last updated: November 04, 2026

Sivec Biotechnologies Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Sivec Biotechnologies Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, STEPHENS, AMELIA CAROLE, who is responsible for the pending office action. The prosecution is being conducted within 1 distinct art unit. Because of this pending action, the company's immediate focus is concentrated on the specific requirements of the examiner and art unit.

The busiest examiner, STEPHENS, AMELIA CAROLE, is the primary point of contact for the 1 pending action. For the practitioner, this means that the outcome of the current prosecution depends on the examination style and technical interpretations of this individual. The alignment of the pending action with the examiner and art unit reflects a narrow and specific interaction with the patent office at this time. This concentration allows for a focused strategy when addressing the outstanding Biotechnology & Pharmaceuticals application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STEPHENS, AMELIA CAROLE 1 66.7% +44.4%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18565595 BACTERIAL DELIVERY OF ANTIBODIES, ANTIBODY DERIVATIVES, AND POLYPEPTIDES TO EUKARYOTIC CELLS STEPHENS, AMELIA CAROLE —

Top Art Units

Art UnitApps
1656 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18565595 BACTERIAL DELIVERY OF ANTIBODIES, ANTIBODY DERIVATIVES, AND POLYPEPTIDES TO EUKARYOTIC CELLS STEPHENS, AMELIA CAROLE 1656 §102§103§112DP Non-Final OA — Pending Nov 30, 2023

Managing Sivec Biotechnologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Sivec Biotechnologies Inc. have?

Sivec Biotechnologies Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Sivec Biotechnologies Inc. applications?

Amelia Carole Stephens has the most, with 1 of Sivec Biotechnologies Inc.'s pending office actions.

What technology area are Sivec Biotechnologies Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month